IQVIA has announced a four-session webcast series on the use of RWE (real world evidence) in drug development leading to regulatory approval. The first session will take place on Wednesday, April 21st at 10 AM EDT and will focus on key tools to maximize the impact of RWE. IQVIA leaders, including Vice President of Patient Centered Endpoints Jean Paty, will discuss an Integrated Evidence Strategy and patient centricity.
“Real world evidence (RWE) is increasingly being used across the product lifecycle. Discover how you can use it to shape trial strategy and design, influence regulatory decision making, and demonstrate commercial differentiation and drug value.” Learn more and register here.
(Source: IQVIA, 2021)